The 72nd Annual Conference of the Israel Heart Society in association with the Israel Society of Cardiothoracic Surgery

Respect The Apex - Deep Learning Enhanced Estimation of Left Ventricular Ejection Fraction: Application in Transthoracic and Point-of-Care Echocardiography

Kobi Faierstein 1,2 Ranel Loutati 1 Michael Fiman 3 Adiel Am-Shalom 3 Noa Rubin 3 Anan Younis 1,2 Uri Manor 1,2 Michal Cohen-Shelly 1 Nimrod Blank 4 Qiong Zhao 5 Robert Klempfner 1,2,3 Ehud Schwammenthal 1,2,3 Ehud Raanani 1,2,3 Elad Maor 1,2,3
1Leviev Cardiovascular Institute, Sheba Medical Center, Ramat Gan, Israel, Israel
2Faculty of Medical and Health Sciences, Tel-Aviv University, Tel-Aviv, Israel., Israel
3Aisap.ai, Aisap.ai, Israel
4Division of cardiovascular medicine, Echocardiography unit, Baruch-Padeh Medical Center, Poria, Israel, Israel
5Inova Heart and Vascular Institute, Inova Fairfax Hospital, USA

Transthoracic echocardiography (TTE) is increasingly utilized by point-of-care ultrasound (POCUS). This study aimed to evaluate whether artificial intelligence (AI) could estimate left ventricular ejection fraction (LVEF) using standard TTE without measuring chamber size or requiring image segmentation, focusing on the parasternal long-axis and apical four-chamber views. The Aisap.ai algorithm was applied in a deep learning network training with data from 76,342 patients for training (62%), 22,825 for validation (19%), and 20,960 for testing (17%), all of whom underwent comprehensive transesophageal echocardiography (TEE) studies between 2007 and 2021. An additional cohort of 556 patients from a different hospital provided external validation, while a prospective validation was conducted with a POCUS cohort of 237 patients. The final hold-out cohort included 20,960 patients with a median age of 66 years, of whom 58% were men. LVEF was estimated as a continuous variable, yielding a mean average error (MAE) of 3.4, a root mean square error (RMSE) of 4.83, and a Pearson correlation coefficient of 0.92. Results were consistent across the external validation and prospective POCUS cohort. During a median follow-up of five years, 4,682 patients (23.1%) died. A multivariate Cox regression model indicated that decreased LVEF estimation by the AI was linked to a 39% increased risk of death (95% CI 1.31-1.48, p<0.001). Consistent outcomes were found in a sub-group analysis of patients with preserved and reduced ejection fractions. Additionally, those in the discrepancy group faced a 58% increased risk of heart failure hospitalizations (95% CI 1.32-1.89, p<0.001). In conclusion, AI can effectively estimate LVEF and serves as an independent predictor of heart failure hospitalization and survival, suggesting its potential for risk stratification at the point of care.
This plot demonstrates the mortality rates of the three LVEF discrepancy group: 33%, 36%, and 46% among patients with LVEF discrepancy < 0, LVEF discrepancy between 0 and 5, and LVEF discrepancy > 5, respectively. Compared to the reference group of patients with LVEF discrepancy between 0 and 5, patients with negative LVEF discrepancy had 6% less mortality (95% CI 0.89-0.98, p=0.01), whereas among patients with LVEF discrepancy of 5 or more the risk for mortality was higher by 34% (95% 1.25-1.43, p<0.001). CI: confidence interval, HR: hazard ratio. LVEF: left ventricular ejection fraction.LVEF and age adjusted Cox survival analysis. The adjusted Cox model demonstrated that patients in the LDG were 39% more likely to die during the follow-up period compared with those in the non-LDG (95% CI 1.31-1.48, p<0.001). CI: confidence interval, LDG: LVEF discrepancy group (AILVEF < ReportedLVEF), LVEF: left ventricular ejection fraction.Kaplan-Meier cumulative incidence curves of HF admission demonstrating higher incidence of hospitalization due to HF among patients in the LDG compared to patients in the non-LDG. Log rank p < 0.001. LDG: LVEF discrepancy group (AILVEF < ReportedLVEF), LVEF: left ventricular ejection fraction.